- (a) Each preliminary oral fluid screening test conducted shall be performed on a device approved by the director.
- (b) The device approved for use shall be the Abbott SoToxa™ model.
- (c) Each agency shall be responsible for the training of preliminary oral fluid screening test device operators. All training shall follow the operational instructions supplied by the manufacturer for the device in use.
(Authorized by and implementing K.S.A. 75-712h, as amended by L. 2022, ch. 80, sec. 23; effective Feb. 17, 2023.)